Literature DB >> 35023891

Decreased diversity of salivary microbiome in patients with stable decompensated cirrhosis.

T Oikonomou1, E Cholongitas2, G Gioula3, F Minti3, A Melidou3, E Protonotariou3, E Akriviadis1, I Goulis1.   

Abstract

BACKGROUND: In the setting of the oral-gut-liver axis, microbiome dysbiosis has been associated with decompensated cirrhosis progression. However, little is known on salivary microbiome profiles in stable decompensated patients.
METHODS: We studied patients with stable decompensated cirrhosis (n =28) and matched healthy controls (n =26). There were five patients (17.8 %) with hepatocellular carcinoma (HCC). Microbiomes of the 54 salivary samples were profiled through next-generation sequencing of the 16S-rRNA region in bacteria.
RESULTS: The two study groups (patients and controls) did not differ significantly concerning their baseline characteristics. The most abundant phyla were Firmicutes, Bacteroidetes, Proteobacteria, and Fusobacteria. Proposed dysbiosis ratio Firmicutes/Bacteroidetes was lower in patients than in controls (range: 0.05-2.54 vs. 0.28-2.18, p =0.4), showing no statistical significance. Phylum Deinococcus-Thermus was detected only in controls, while Phylum Planctomycetes only in patients. A-diversity analysis indicated low diversity of salivary microbiome in decompensated patients and patients with HCC, who presented specific discriminative taxa. On principal coordinate analysis (PCoA), the patients' and controls' salivary microbiomes clustered apart, suggesting differences in community composition (PERMANOVA test, p =0.008). Boruta wrapper algorithm selected the most representative genera to classify controls and patients (area under the curve =0.815).
CONCLUSIONS: Patients with stable decompensated cirrhosis of various etiology and history of complications have decreased diversity of their salivary microbiome. PCoA and Boruta algorithm may represent useful tools to discriminate the salivary microbiome in patients with decompensation. Further studies are needed to establish the utility of salivary microbiome analysis, which is easier obtained than fecal, in decompensated cirrhosis. HIPPOKRATIA 2020, 24(4): 157-165. Copyright 2020, Hippokratio General Hospital of Thessaloniki.

Entities:  

Keywords:  Decompensated cirrhosis; bacterial diversity; dysbiosis; salivary microbiome

Year:  2020        PMID: 35023891      PMCID: PMC8747582     

Source DB:  PubMed          Journal:  Hippokratia        ISSN: 1108-4189            Impact factor:   0.471


  38 in total

Review 1.  Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.

Authors:  Gennaro D'Amico; Guadalupe Garcia-Tsao; Luigi Pagliaro
Journal:  J Hepatol       Date:  2005-11-09       Impact factor: 25.083

2.  16S rRNA deep sequencing for the characterization of healthy human pharyngeal microbiome.

Authors:  G Gioula; A Melidou; P Siasios; F Minti; N Malisiovas
Journal:  Hippokratia       Date:  2018 Jan-Mar       Impact factor: 0.471

Review 3.  Altered Microbiota in Cirrhosis and Its Relationship to the Development of Infection.

Authors:  Jasmohan S Bajaj
Journal:  Clin Liver Dis (Hoboken)       Date:  2019-10-09

4.  Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.

Authors:  Yongbin Zeng; Shanjian Chen; Ya Fu; Wennan Wu; Tianbin Chen; Jing Chen; Bin Yang; Qishui Ou
Journal:  J Viral Hepat       Date:  2019-10-29       Impact factor: 3.728

5.  Specific Gut and Salivary Microbiota Patterns Are Linked With Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy.

Authors:  Jasmohan S Bajaj; Andrew Fagan; Melanie B White; James B Wade; Phillip B Hylemon; Douglas M Heuman; Michael Fuchs; Binu V John; Chathur Acharya; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Am J Gastroenterol       Date:  2019-07       Impact factor: 10.864

6.  Compensated cirrhosis: natural history and prognostic factors.

Authors:  P Ginés; E Quintero; V Arroyo; J Terés; M Bruguera; A Rimola; J Caballería; J Rodés; C Rozman
Journal:  Hepatology       Date:  1987 Jan-Feb       Impact factor: 17.425

7.  Cognition and hospitalizations are linked with salivary and faecal microbiota in cirrhosis cohorts from the USA and Mexico.

Authors:  Jasmohan S Bajaj; Aldo Torre; Mayra L Rojas; Andrew Fagan; Ivvone E Nandez; Edith A Gavis; Omar De Leon Osorio; Melanie B White; Michael Fuchs; Masoumeh Sikaroodi; Patrick M Gillevet
Journal:  Liver Int       Date:  2020-04-01       Impact factor: 5.828

Review 8.  Gut microflora in the pathogenesis of the complications of cirrhosis.

Authors:  Guadalupe Garcia-Tsao; Reiner Wiest
Journal:  Best Pract Res Clin Gastroenterol       Date:  2004-04       Impact factor: 3.043

Review 9.  The gut-liver axis in liver disease: Pathophysiological basis for therapy.

Authors:  Agustín Albillos; Andrea de Gottardi; María Rescigno
Journal:  J Hepatol       Date:  2019-10-14       Impact factor: 25.083

10.  Chapter 12: Human microbiome analysis.

Authors:  Xochitl C Morgan; Curtis Huttenhower
Journal:  PLoS Comput Biol       Date:  2012-12-27       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.